ロード中...
2194. Procalcitonin-Guided Antibiotic Strategy for Lower Respiratory Tract Infections: Outcomes and Safety of Withholding Antibiotics
BACKGROUND: Procalcitonin (PCT) is a promising and well-studied marker in differentiating viral from bacterial lower respiratory tract infections (LRTI). Antibiotics are not recommended when PCT is normal (< 0.25 μg/L). Despite this, it has not been the standard of care due to safety concerns of...
保存先:
| 出版年: | Open Forum Infect Dis |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6810131/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofz360.1874 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|